Professor Erika Lietzan was recently interviewed by a reporter for The Atlantic in connection with the use of “citizen petitions” at the U.S. Food & Drug Administration (FDA). A recent article in the New England Journal of Medicine had pointed out that many petitions are filed by brand-name drug companies about products proposed by generic drug companies. Professor Lietzan commented…